142 related articles for article (PubMed ID: 28964854)
1. Estimating health benefits and cost-savings for achieving the Healthy People 2020 objective of reducing invasive colorectal cancer.
Hung MC; Ekwueme DU; White A; Rim SH; King JB; Wang JD; Chang SH
Prev Med; 2018 Jan; 106():38-44. PubMed ID: 28964854
[TBL] [Abstract][Full Text] [Related]
2. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
Tscheulin DK; Drevs F
Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
[TBL] [Abstract][Full Text] [Related]
3. Whole Grain Intakes Are Associated with Healthcare Cost Savings Following Reductions in Risk of Colorectal Cancer and Total Cancer Mortality in Australia: A Cost-of-Illness Model.
Abdullah MMH; Hughes J; Grafenauer S
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578860
[TBL] [Abstract][Full Text] [Related]
4. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC
Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812
[TBL] [Abstract][Full Text] [Related]
5. [Health economics analysis of colorectal screening].
Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
[TBL] [Abstract][Full Text] [Related]
6. Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening.
Goede SL; Kuntz KM; van Ballegooijen M; Knudsen AB; Lansdorp-Vogelaar I; Tangka FK; Howard DH; Chin J; Zauber AG; Seeff LC
Med Care; 2015 Jul; 53(7):630-8. PubMed ID: 26067885
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening differential costs for younger versus older Americans.
Ladabaum U; Phillips KA
Am J Prev Med; 2006 May; 30(5):378-84. PubMed ID: 16627125
[TBL] [Abstract][Full Text] [Related]
8. Population screening for colorectal cancer: the implications of an ageing population.
Macafee DA; Waller M; Whynes DK; Moss S; Scholefield JH
Br J Cancer; 2008 Dec; 99(12):1991-2000. PubMed ID: 19034277
[TBL] [Abstract][Full Text] [Related]
9. The impact of chronic disease self-management programs: healthcare savings through a community-based intervention.
Ahn S; Basu R; Smith ML; Jiang L; Lorig K; Whitelaw N; Ory MG
BMC Public Health; 2013 Dec; 13():1141. PubMed ID: 24314032
[TBL] [Abstract][Full Text] [Related]
10. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
11. The value of colonoscopic colorectal cancer screening of adults aged 50 to 64.
Fitch K; Pyenson B; Blumen H; Weisman T; Small A
Am J Manag Care; 2015 Jul; 21(7):e430-8. PubMed ID: 26295271
[TBL] [Abstract][Full Text] [Related]
12. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
Daniels K; McKee M
J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
[TBL] [Abstract][Full Text] [Related]
13. Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention.
Dehmer SP; Maciosek MV; LaFrance AB; Flottemesch TJ
Ann Fam Med; 2017 Jan; 15(1):23-36. PubMed ID: 28376458
[TBL] [Abstract][Full Text] [Related]
14. Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S.
Kim DD; Wilde PE; Michaud DS; Liu J; Lizewski L; Onopa J; Mozaffarian D; Zhang FF; Wong JB
Am J Prev Med; 2019 Nov; 57(5):e143-e152. PubMed ID: 31564600
[TBL] [Abstract][Full Text] [Related]
15. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
16. Does prevention save costs? Considering deferral of the expensive last year of life.
Gandjour A; Lauterbach KW
J Health Econ; 2005 Jul; 24(4):715-24. PubMed ID: 15960993
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness Analysis of The Real Cost Campaign's Effect on Smoking Prevention.
MacMonegle AJ; Nonnemaker J; Duke JC; Farrelly MC; Zhao X; Delahanty JC; Smith AA; Rao P; Allen JA
Am J Prev Med; 2018 Sep; 55(3):319-325. PubMed ID: 30122214
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
19. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
20. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
